Evidence map›Paper›PMID 25851941›Full record

ArticleNature communications2015

Making water-soluble integral membrane proteins in vivo using an amphipathic protein fusion strategy.

Dario Mizrachi, Yujie Chen, Jiayan Liu, Hwei-Ming Peng, Ailong Ke, Lois Pollack, Raymond J Turner, Richard J Auchus, Matthew P DeLisa

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Solubilization of Membrane Proteins using designed protein WRAPS.bioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Dario MizrachiSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York 14853, USA.
Yujie ChenSchool of Applied and Engineering Physics, Cornell University, Ithaca, New York 14853, USA.
Jiayan LiuDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.
Hwei-Ming PengDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.
Ailong KeDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, New York 14850, USA.
Lois PollackSchool of Applied and Engineering Physics, Cornell University, Ithaca, New York 14853, USA.
Raymond J TurnerDepartment of Biological Sciences, University of Calgary, Calgary, Alberta, Canada T2N 1N4.
Richard J AuchusDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.
Matthew P DeLisaSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York 14853, USA.
Cornell University · USUniversity of Michigan–Ann Arbor · USUniversity of Calgary · CA

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joyce Lee · 2010 to 2026
$20.3M
Overall (pp. 40-62)P41GM103485 · NIGMS · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2012 to 2018
$15.5M
Activation of androgen biosynthesis and drug metabolism by cytochrome b5R01GM086596 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI RICHARD J. AUCHUS · 2009 to 2026
$4.8M
Structure and mechanism of CRISPR interference.R01GM102543 · NIGMS · CORNELL UNIVERSITY · PI KE, AILONG · 2013 to 2015
$917k
Discovery of antibodies that bind G protein-coupled receptorsR21DA031409 · NIDA · CORNELL UNIVERSITY · PI DELISA, MATTHEW P · 2011 to 2012
$437k
NIDA NIH HHS R21 DA031409NIDA NIH HHS R21DA031409-01NIDDK NIH HHS DK089503NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK089503NIGMS NIH HHS GM-103485NIGMS NIH HHS P41 GM103485NIGMS NIH HHS R01 GM086596NIGMS NIH HHS R01GM086596NIGMS NIH HHS R01 GM102543
6 · The paper itself

Abstract

Integral membrane proteins (IMPs) play crucial roles in all cells and represent attractive pharmacological targets. However, functional and structural studies of IMPs are hindered by their hydrophobic nature and the fact that they are generally unstable following extraction from their native membrane environment using detergents. Here we devise a general strategy for in vivo solubilization of IMPs in structurally relevant conformations without the need for detergents or mutations to the IMP itself, as an alternative to extraction and in vitro solubilization. This technique, called SIMPLEx (solubilization of IMPs with high levels of expression), allows the direct expression of soluble products in living cells by simply fusing an IMP target with truncated apolipoprotein A-I, which serves as an amphipathic proteic 'shield' that sequesters the IMP from water and promotes its solubilization.

Indexed as

Hydrophobic and Hydrophilic InteractionsAntigens, SurfaceAntiportersApolipoprotein A-IBacterial Outer Membrane ProteinsBacterial VaccinesBorrelia burgdorferiEscherichia coliEscherichia coli ProteinsLipoproteinsMembrane ProteinsSolubilityAntigens, SurfaceAntiportersApolipoprotein A-IBacterial Outer Membrane ProteinsBacterial VaccinesEmrE protein, E coliEscherichia coli ProteinsLipoproteinsMembrane ProteinsOspA protein

Identifiers

PMID25851941
PMCPMC4403311
OpenAlexW1981070004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.